DK0502092T3 - Oralt præparat til behandling af inflammatoriske tarmsygdomme - Google Patents

Oralt præparat til behandling af inflammatoriske tarmsygdomme

Info

Publication number
DK0502092T3
DK0502092T3 DK91900414.3T DK91900414T DK0502092T3 DK 0502092 T3 DK0502092 T3 DK 0502092T3 DK 91900414 T DK91900414 T DK 91900414T DK 0502092 T3 DK0502092 T3 DK 0502092T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory bowel
oral preparation
bowel diseases
crohn
Prior art date
Application number
DK91900414.3T
Other languages
Danish (da)
English (en)
Inventor
Jan Ulmius
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0502092(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco Ab filed Critical Draco Ab
Application granted granted Critical
Publication of DK0502092T3 publication Critical patent/DK0502092T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DK91900414.3T 1989-11-22 1990-11-15 Oralt præparat til behandling af inflammatoriske tarmsygdomme DK0502092T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
DK0502092T3 true DK0502092T3 (da) 1995-12-27

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900414.3T DK0502092T3 (da) 1989-11-22 1990-11-15 Oralt præparat til behandling af inflammatoriske tarmsygdomme

Country Status (36)

Country Link
US (1) US6423340B1 (zh)
EP (1) EP0502092B1 (zh)
JP (1) JP3145111B2 (zh)
KR (1) KR0179042B1 (zh)
AT (1) ATE125445T1 (zh)
AU (1) AU643021B2 (zh)
CA (1) CA2071518C (zh)
DE (1) DE69021214T2 (zh)
DK (1) DK0502092T3 (zh)
EG (1) EG19642A (zh)
ES (1) ES2074698T3 (zh)
FI (2) FI104949B (zh)
GR (1) GR3017691T3 (zh)
HK (1) HK51897A (zh)
HR (1) HRP920632B1 (zh)
HU (2) HU216836B (zh)
IE (1) IE74854B1 (zh)
IL (1) IL96415A (zh)
IS (1) IS1858B (zh)
LT (1) LT3696B (zh)
LV (1) LV10183B (zh)
MY (1) MY104535A (zh)
NO (1) NO304010B1 (zh)
NZ (1) NZ235807A (zh)
PL (1) PL166506B1 (zh)
PT (1) PT95946A (zh)
RU (1) RU2134104C1 (zh)
SA (1) SA90110123B1 (zh)
SE (1) SE8903914D0 (zh)
SG (1) SG54210A1 (zh)
SI (1) SI9012150A (zh)
TW (1) TW250435B (zh)
UA (1) UA37196C2 (zh)
WO (1) WO1991007172A1 (zh)
YU (1) YU48583B (zh)
ZA (1) ZA908777B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
ES2137353T3 (es) * 1993-01-08 1999-12-16 Astra Ab Nuevos derivados esteroides especificos del colon o del ileon.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
CA2271560C (en) * 1996-11-15 2003-09-23 Mayo Foundation For Medical Education And Research Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
JP2005508836A (ja) * 2001-03-15 2005-04-07 エンテロン ファーマシューティカルズ インコーポレーティッド 局所作用性コルチコステロイドを用いる胃腸管の炎症性疾患の治療方法
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
DK1572217T3 (da) 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
EP1607087A1 (en) * 2003-03-27 2005-12-21 Hisamitsu Pharmaceutical Co., Inc. Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
EP1670481B1 (en) * 2003-09-15 2010-08-04 Nycomed GmbH Use of ciclesonide for the treatment of inflammatory bowel diseases
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
WO2007056539A2 (en) * 2005-11-08 2007-05-18 Medarex, Inc. Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
CN102238868A (zh) * 2008-10-03 2011-11-09 福尔克博士药物有限责任公司 使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
US8945616B2 (en) 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
PE20140887A1 (es) * 2011-02-04 2014-08-14 Optimer Pharmaceuticals Inc Tratamiento de infecciones bacterianas
MD480Z (en) * 2011-07-07 2012-09-30 Elvira Andon Method for treating acute ulcerative nonspecific colitis
NO2659881T3 (zh) 2012-04-30 2018-04-28
KR102174942B1 (ko) 2013-10-29 2020-11-06 틸로츠 파마 아게 지연 방출 약물 제형
US9707182B2 (en) * 2015-09-11 2017-07-18 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
CN108601745B (zh) * 2016-02-09 2021-12-07 阿尔比里奥公司 口服考来烯胺制剂及其用途
CA3011565C (en) * 2016-02-09 2024-01-02 Albireo Ab Oral cholestyramine formulation and use thereof
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (zh) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
AU7786491A (en) 1991-06-13
PT95946A (pt) 1991-09-13
SG54210A1 (en) 1998-11-16
DE69021214T2 (de) 1996-01-04
EP0502092A1 (en) 1992-09-09
FI922325A0 (fi) 1992-05-21
FI19991893A (fi) 1999-09-06
EG19642A (en) 1995-08-30
NZ235807A (en) 1993-02-25
IE904170A1 (en) 1991-05-22
RU2134104C1 (ru) 1999-08-10
NO922004D0 (no) 1992-05-21
LTIP1751A (en) 1995-07-25
HU9201700D0 (en) 1992-08-28
FI922325A (fi) 1992-05-21
ATE125445T1 (de) 1995-08-15
FI104949B (fi) 2000-05-15
GR3017691T3 (en) 1996-01-31
IS3644A7 (is) 1991-05-23
NO304010B1 (no) 1998-10-12
UA37196C2 (uk) 2001-05-15
IS1858B (is) 2003-03-27
NO922004L (no) 1992-05-21
JP3145111B2 (ja) 2001-03-12
JPH05501705A (ja) 1993-04-02
LV10183A (lv) 1994-10-20
DE69021214D1 (de) 1995-08-31
US6423340B1 (en) 2002-07-23
PL287844A1 (en) 1991-12-02
IL96415A (en) 1995-11-27
HUT60630A (en) 1992-10-28
HK51897A (en) 1997-05-02
HU216836B (hu) 1999-09-28
LT3696B (en) 1996-02-26
AU643021B2 (en) 1993-11-04
PL166506B1 (pl) 1995-05-31
MY104535A (en) 1994-04-30
KR0179042B1 (ko) 1999-03-20
ZA908777B (en) 1991-07-31
TW250435B (zh) 1995-07-01
IL96415A0 (en) 1991-08-16
SA90110123B1 (ar) 1999-06-06
YU48583B (sh) 1998-12-23
CA2071518C (en) 2002-11-12
CA2071518A1 (en) 1991-05-23
SI9012150A (sl) 1998-08-31
IE74854B1 (en) 1997-08-13
LV10183B (en) 1995-08-20
WO1991007172A1 (en) 1991-05-30
HRP920632B1 (en) 1999-10-31
YU215090A (sr) 1996-01-09
HRP920632A2 (en) 1995-04-30
ES2074698T3 (es) 1995-09-16
SE8903914D0 (sv) 1989-11-22
EP0502092B1 (en) 1995-07-26
KR920703025A (ko) 1992-12-17

Similar Documents

Publication Publication Date Title
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
ATE232396T1 (de) Oxydiertes thymosin beta 4
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
MD990258A (en) Method of treatment of the acute viral hepatitis B
NL187299B (nl) Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
CA2091134A1 (en) Therapeutic agent for threatened abortion
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DK0621789T3 (da) Farmaceutiske pentapeptidpræparater og fremgangsmåder til anvendelse deraf
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero
MD1780G2 (ro) Metodă de tratament al pacienţilor cu ciroze hepatice
DE3676806D1 (de) Pharmazeutische zusammensetzung und behandlung.
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия